Pharmaceutical Equipment Market Size (2024 - 2029)

The pharmaceutical equipment market is anticipated to experience growth over the forecast period, driven by advancements in the pharmaceutical and biopharmaceutical sectors and technological innovations. The market's expansion is supported by investments in production facilities and research and development centers, which enhance the capacity for vaccine and drug development. Despite initial setbacks due to the COVID-19 pandemic, the market rebounded as pharmaceutical machinery played a crucial role in producing COVID-19 related medications. Government and pharmaceutical company investments are expected to further boost the market, although the high cost of equipment may pose a challenge to growth.

Market Size of Pharmaceutical Equipment Industry

Pharmaceutical Equipment Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.60 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pharmaceutical Equipment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Equipment Market Analysis

The pharmaceutical equipment market is expected to grow at a CAGR of 4.6% over the forecast period.

Due to limitations on medicine production in biotech and pharmaceutical manufacturing facilities, trade restrictions, and a shortage of raw materials, the COVID-19 pandemic had a negative influence on the market in its earliest stages. However, the market recovered in the second phase of the pandemic thanks to the use of pharmaceutical machinery for medications connected to COVID-19 and the initiatives of important market participants. For instance, in May 2022, an article published in the National Library of Medicine stated that lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to be very successful in the fight against the COVID-19 pandemic. Thus, the long-term storage of mRNA-LNP vaccines with lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Hence, such advantages are expected to increase the market growth. Furthermore, initiatives such as in June 2022, Pfizer announced its commitment to United States manufacturing with a USD 120 million investment at its Kalamazoo, Michigan, facility, enabling United States-based production in support of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets). Thus, such initiatives significantly impacted the market during the COVID-19 pandemic.

Factors such as high growth in the pharmaceutical and biopharmaceutical industry and technological developments are expected to increase market growth. For instance, in March 2022, Japan launched a new research and development center, for USD 1.6 billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. The establishment of an R&D facility for innovative partnerships and budget management will be under Supervisory Control And Data Acquisition (SCADA). Similarly, in December 2021, the Board of Global Alliance for Vaccine and Immunization (Gavi) approved an investment to support the malaria vaccine introduction, procurement, and delivery for Gavi-eligible countries in sub-Saharan Africa in 2022-2025. An initial investment of USD 155.7 million for 2022-2025 will initiate the implementation of this additional tool in the combat against malaria. Thus, such investments by the governments are expected to increase the adoption of pharmaceutical equipment which is expected to increase market growth over the forecast period.

Furthermore, investments by pharmaceutical companies in its production are another factor driving the market growth. For instance, in November 2021, Sartorius invested USD 300 million to launch cell culture media production and assemble sterile systems for efficient and flexible manufacturing of biopharmaceuticals in South Korea. Thus, such initiatives are expected to increase market growth over the forecast period. Similarly, a rise in technological developments based on agreements between industry players is expected to drive market growth. For instance, in July 2021, Huhtamaki and Syntegon agreed to create a paper-based tablet packaging solution for the pharmaceutical and healthcare industries. However, the high cost of equipment is expected to hinder market growth.

Pharmaceutical Equipment Industry Segmentation

As per the scope, pharmaceutical equipment helps manufacturers in the production of drugs with desired qualities and properties. The Pharmaceutical Equipment Market is Segmented by Type (Weighing Equipment, Lyophilizer, Pharmaceutical Water Equipment, Granulating Equipment, Packaging Equipment, and Others), Formulation (Tablets, Capsules, Injectables, and Other Formulations), End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.

By Type
Weighing Equipment
Lyophilizer
Pharmaceutical Water Equipment
Granulating Equipment
Packaging Equipment
Others
By Formulation
Tablets
Capsules
Injectables
Other Formulations
By End User
Pharmaceutical Manufacturing Companies
Contract Manufacturing Companies
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Pharmaceutical Equipment Market Size Summary

The pharmaceutical equipment market is poised for steady growth over the forecast period, driven by advancements in the pharmaceutical and biopharmaceutical sectors. The initial setbacks caused by the COVID-19 pandemic, such as trade restrictions and raw material shortages, were mitigated by the increased demand for pharmaceutical machinery to support COVID-19 related medications. Key industry players, through strategic investments and innovations, played a crucial role in the market's recovery. For instance, significant investments in manufacturing facilities and the development of advanced technologies, such as lyophilization for mRNA vaccines, have bolstered market expansion. Additionally, government initiatives and investments in research and development, particularly in regions like North America and Japan, are expected to further propel market growth by enhancing the adoption of pharmaceutical equipment.

The market's growth trajectory is also supported by the rising acceptance of biopharmaceutical manufacturing equipment and the increasing utilization of lyophilizers in drug manufacturing processes. Investments by pharmaceutical companies in production capabilities, coupled with technological collaborations, are driving the market forward. However, the high cost of equipment remains a challenge. The market is moderately consolidated, with major players like Alexanderwerk, ALFA LAVAL, and GEA Group dominating the landscape. Ongoing product launches and strategic expansions, such as those by Telstar and Fluid Air, are anticipated to contribute to the market's development. Overall, the pharmaceutical equipment market is expected to experience sustained growth, supported by technological advancements, strategic investments, and favorable government policies.

Explore More

Pharmaceutical Equipment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 High Growth in Pharmaceutical and Biopharmaceutical Industry

      2. 1.2.2 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Equipment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Weighing Equipment

      2. 2.1.2 Lyophilizer

      3. 2.1.3 Pharmaceutical Water Equipment

      4. 2.1.4 Granulating Equipment

      5. 2.1.5 Packaging Equipment

      6. 2.1.6 Others

    2. 2.2 By Formulation

      1. 2.2.1 Tablets

      2. 2.2.2 Capsules

      3. 2.2.3 Injectables

      4. 2.2.4 Other Formulations

    3. 2.3 By End User

      1. 2.3.1 Pharmaceutical Manufacturing Companies

      2. 2.3.2 Contract Manufacturing Companies

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Pharmaceutical Equipment Market Size FAQs

The Pharmaceutical Equipment Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)

Alexanderwerk, ALFA LAVAL, GEA Group, Korber AG and LFA Machines Oxford LTD are the major companies operating in the Pharmaceutical Equipment Market.

Pharmaceutical Equipment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)